Terns Pharmaceuticals (TERN)
(Delayed Data from NSDQ)
$7.46 USD
-0.31 (-3.99%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $7.46 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.35 |
EPS Last Quarter | -0.30 |
Last EPS Surprise | 16.67% |
ABR | 1.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.41 |
Next Year | -1.47 |
EPS (TTM) | -1.26 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.35 | -0.42 | -1.41 | -1.47 |
# of Estimates | 4 | 3 | 4 | 4 |
Most Recent Consensus | -0.33 | -0.36 | -1.36 | -1.27 |
High Estimate | -0.32 | -0.32 | -1.25 | -1.27 |
Low Estimate | -0.37 | -0.58 | -1.63 | -1.90 |
Year ago EPS | -0.25 | -0.42 | -1.27 | -1.41 |
Year over Year Growth Est. | -40.00% | 0.00% | -11.02% | -4.26% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.35 | -0.42 | -1.41 | -1.47 |
7 Days Ago | -0.35 | -0.42 | -1.41 | -1.47 |
30 Days Ago | -0.35 | -0.42 | -1.41 | -1.47 |
60 Days Ago | -0.35 | -0.42 | -1.41 | -1.47 |
90 Days Ago | -0.35 | -0.42 | -1.46 | -1.51 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.35 | -0.42 | -1.41 | -1.47 |
Zacks Consensus Estimate | -0.35 | -0.42 | -1.41 | -1.47 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.30 | -0.29 | -0.42 | -0.25 | NA |
Estimate | -0.36 | -0.29 | -0.31 | -0.32 | NA |
Difference | 0.06 | 0.00 | -0.11 | 0.07 | 0.01 |
Surprise | 16.67% | 0.00% | -35.48% | 21.88% | 0.77% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more